All In Biotech

Drug Trial Radar · NCT01686152

Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis of the Face or Balding Scalp

Last checked: Nov 20, 2026Latest source record: Nov 24, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 589 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

589

Actual

Start

Sep 2012

Primary completion

Aug 2013

Study completion Aug 2013

Sponsor

Lead sponsor
Teva Pharmaceuticals USATeva (TEVA)
Sponsor type
Industry
First posted
Sep 17, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Other
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To determine the comparability of the safety and efficacy of Imiquimod Cream, 3.75% and Zyclara (imiquimod) Cream, 3.75% (the reference listed drug) in subjects with actinic keratosis (AK) of the face or balding scalp. It will also be determined whether the efficacy of each of the two active treatments is superior to that of the Vehicle cream.

Conditions

  • Actinic Keratosis

Interventions

  • Imiquimod Cream, 3.75%Drug

  • Zyclara®Drug

  • Vehicle of Test ProductOther

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment Success/Failure at Visit 5/Week 14Time frame: 14 Weeks

Locations

23 sites in 1 country. Site status is shown where the registry gives one.

  • Radiant Research, Inc.

    Tucson, Arizona

  • Encino Research Center

    Encino, California

  • Dermatology Research Associates

    Los Angeles, California

  • Northern California Research

    Sacramento, California

  • Skin Surgery Medical Group, Inc.

    San Diego, California

  • Longmont Clinic, PC

    Longmont, Colorado

  • Visions Clinical Research

    Boynton Beach, Florida

  • Tampa Bay Medical Research

    Clearwater, Florida

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida

  • International Dermatology Research, Inc.

    Miami, Florida

  • Tory Sullivan, M.D., P.A.

    North Miami Beach, Florida

  • Park Avenue Dermatology, PA

    Orange Park, Florida

  • Leavitt Medical Associates of Florida dba Ameriderm Research

    Ormond Beach, Florida

  • Radiant Research, Inc.

    Pinellas Park, Florida

  • MedaPhase, Inc.

    Newnan, Georgia

  • Altman Dermatology Associates

    Arlington Heights, Illinois

  • The Indiana Clinical Trials Center

    Plainfield, Indiana

  • Dermatology Specialists Research LLC

    Louisville, Kentucky

  • Radiant Research, Inc.

    Cincinnati, Ohio

  • Oregon Medical Research Center, PC

    Portland, Oregon

  • Philadelphia Institute of Dermatology

    Fort Washington, Pennsylvania

  • Omega Medical Research

    Warwick, Rhode Island

  • Research Across America

    Dallas, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.